News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nicolette Charles A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/25/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Disposed/sold 27,150 shares
@ $0 |
|
| 03/30/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 27,150 shares
@ $0 |
|
| 01/12/2018 |
4/A
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 100,250 shares
@ $0.1646, valued at
$16.5k
|
|
| 01/12/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 100,250 shares
@ $0.1646, valued at
$16.5k
|
|
| 01/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/14/2016 |
4
| Nicolette Charles A. (Chief Scientific Officer) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 10,924 shares
@ $0
Granted 3,375 options to buy
@ $6.09, valued at
$20.6k
Granted 175,000 options to buy
@ $7.41, valued at
$1.3M
|
|
|
|